Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Frontiers in Oncology|December 26, 2022
WSP from "Nostoc commune" Vauch. suppresses gastric cancer migration via EGFRVIII signalingXiaoxia Chen, Wenqi Bai, Xiangrong Liu, et al.
Frontiers in Oncology|June 17, 2022
An Applicable Machine Learning Model Based on Preoperative Examinations Predicts Histology, Stage, and Grade for Endometrial CancerYing Feng, Zhixiang Wang, Meizhu Xiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2022
Low dinosaur biodiversity in central China 2 million years prior to the end-Cretaceous mass extinctionFei Han, Qiang Wang, Huapei Wang, et al.
Leukemia & Lymphoma|October 16, 2025
Pediatric-inspired regimen abrogates the poor prognosis of adult early T-cell precursor acute lymphoblastic leukemiaJieping Lin, Chengming He, Zihong Cai, et al.
Journal of Translational Medicine|May 28, 2025
Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trialBailin He, Ren Lin, Na Xu, et al.
BMC Medicine|August 27, 2025
Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled studyKaibo Yang, Jing Du, Fen Huang, et al.
BMJ Public Health|February 28, 2025
Association of pre-diabetes with the risks of adverse health outcomes and complex multimorbidity: evidence from population-based studies in the NIS and UK BiobankYafei Wu, Xiude Fan, Yingzhou Shi, et al.
Transplantation and Cellular Therapy|September 1, 2022
Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow GraftsFen Huang, Xiangzong Zeng, Zhiping Fan, et al.
American Journal of Hematology|January 2, 2023
Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT: An open-label, multicenter, randomized phase 3 trialHui Liu, Fen Huang, Yu Zhang, et al.
Cancer|March 22, 2022
A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemiaXiaoxia Chen, Junwei Huang, Na Xu, et al.
Pageof 31